발행물

논문
특허
저서
컨퍼런스

전체 논문

207

41

Dietary schizophyllan reduces mitochondrial damage by activating          SIRT3 in mice.
Lee D, Kim YR, Kim JS, Kim D, Kim S, Kim SY, Jang K, Lee JD, Yang CS*
Arch Pharm Res., 2020

42

Rifamycin O, an alternative anti-Mycobacterium abscessus        agent.
Hanh BTB, Park JW, Kim TH, Kim JS, Yang CS, Jang K, Cui J, Oh DC, Jang J
Molecules, 2020

43

Sustainable Nanosheet Antioxidants for Sepsis        Therapy via Scavenging Intracellular Reactive Oxygen and Nitrogen Species.
Yim DB, Lee DE, So Y, Choi C, Son W, Jang K, Yang CS*, Kim JH*
ACS Nano, 2020

44

Host-directed therapy in tuberculosis: targeting host metabolism.
Kim JS, Kim YR, Yang CS*
Front. Immunol, 2020

45

A novel totivirus alters gene expression and vacuolar morphology in Malassezia cells and induces a TLR3-mediated inflammatory immune response.
Park M, Cho YJ, Kim D, Yang CS, Lee SM, Dawson T, Nakamizo S, Kabashima K, Lee YW, Jung WH
mBio, 2020

46

Etamycin as a Novel Mycobacterium abscessus Inhibitor.
Hanh BTB, Kim TH, Park JW, Lee DG, Kim JS, Du YE, Yang CS, Oh DC, Jang J
Int J Mol Sci., 2020

47

Toxoplasma gondii GRA9 Regulates the Activation of NLRP3      Inflammasome to Exert Anti-Septic Effects in Mice.
Kim JS, Mun SJ, Cho E, Kim D, Son W, Jeon HI, Kim HK, Jang K, Yang CS*
Int J Mol Sci., 2020

48

Mycobacteria Rv2626c-derived peptide as a therapeutic agent for            sepsis.
Kim SY, Kim D, Kim S, Lee D, Mun SJ, Cho E, Son W, Jang K, Yang CS*
EMBO Mol Med, 2020

49

Latest Comprehensive Knowledge of the Crosstalk between TLR Signaling and Mycobacteria and the Antigens      Driving the Process.
Kim JS, Kim YR, Yang CS*
J Microbiol Biotechnol., 2019

50

Toxoplasma gondii GRA8-derived peptide immunotherapy improves tumor targeting        of colorectal cancer.
Kim JS, Lee D, Kim D, Mun SJ, Cho E, Son W, Yang CS*
Oncotarget., 2020